Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Introduction<p>Although the transcatheter arterial chemoembolization (TACE) combined with sintilimab and bevacizumab improves outcomes in unresectable HCC (uHCC), predictive tools are lacking. This study developed and validated a prognostic model for triple therapy efficacy.</p>Methods&l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Liying Ren (11143129) (author)
Altres autors: Dongbo Chen (10430738) (author), Xue Zhang (166886) (author), Shaoping She (22678979) (author), Ran Fei (93650) (author), Xu Cong (159269) (author), Shaowei Mu (22678982) (author), Yuchen Zhou (1601536) (author), Jie Gao (10266) (author), Weijia Liao (492662) (author), Hongsong Chen (159274) (author)
Publicat: 2025
Matèries:
Genetic Immunology
hepatocellular carcinoma
immunotherapy
transcatheter arterial chemoembolization
prognostic model
FAAP score
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
Sigues el primer a deixar un comentari!
Abans heu d’iniciar sessió

Ítems similars